Related by context. Frequent words. (Click for all words.) 73 Act PDUFA date 67 Act PDUFA 65 Prescription Drug User Fee 64 PDUFA 63 PDUFA date 63 FDA Accepts 62 Cladribine 60 pediatric exclusivity 60 Generic Version 60 Pirfenidone 59 dalbavancin 59 FDA Advisory Panel 59 Pivotal Phase 59 Phase III Clinical Trial 59 Onsolis 58 Patient Enrollment 58 TYGACIL 58 Marketing Authorization 58 application sNDA 57 Extended Release 57 Oral Solution 57 PRISTIQ 57 See BioWorld Today 57 Priority Review 57 Octreotide 57 FDA Orphan Drug 57 Marketing Authorization Application 57 QNEXA 56 Pivotal Phase III 56 Extavia 56 Application BLA 56 methylnaltrexone 56 orphan medicinal product 56 Vfend 56 Natalizumab 56 Anti TNF 56 Biosimilars 56 Ofatumumab 56 VALSTAR 56 IRESSA 56 LIALDA 56 Drug Candidate 56 Dasatinib 56 Telavancin 56 NOXAFIL 55 ONSOLIS 55 Cethromycin 55 Pivotal Trial 55 Emend 55 Plenaxis R 55 submitted Biologics License 55 Extended Release Tablets 55 BioDelivery Sciences 55 MHLW 55 BEMA TM Fentanyl 55 Pulmonary Arterial Hypertension 55 ezogabine 55 Intuniv 55 Angiox 55 Positive Opinion 55 FIRAZYR 55 Panzem R 55 Exalgo 55 Fast Track Designation 55 Investigational Device Exemption 55 Ixempra 55 Ferumoxytol 55 Phase III Trial 55 Zelrix 55 Presents Positive 55 NUVIGIL 54 FDA approvable letter 54 orphan designation 54 ixabepilone 54 Print Issue 54 Lamivudine 54 supplemental Biologics License Application 54 Oncologic Drugs Advisory 54 Vandetanib 54 Icatibant 54 IND submission 54 Completes Enrollment 54 Abstral 54 PROMACTA 54 Tesetaxel 54 Cimzia R 54 Ondansetron 54 Avanafil 53 Cervical Cancer Vaccine 53 BLA submission 53 alvimopan 53 Clinical Trial Results 53 Cold Medicines 53 Biologics License Application BLA 53 Elesclomol 53 submitted Marketing Authorization 53 Mutual Recognition Procedure 53 generic biologic 53 Adalimumab 53 Market Approval PMA 53 Complete Response